317 related articles for article (PubMed ID: 28342833)
1. A high density CHO-S transient transfection system: Comparison of ExpiCHO and Expi293.
Jain NK; Barkowski-Clark S; Altman R; Johnson K; Sun F; Zmuda J; Liu CY; Kita A; Schulz R; Neill A; Ballinger R; Patel R; Liu J; Mpanda A; Huta B; Chiou H; Voegtli W; Panavas T
Protein Expr Purif; 2017 Jun; 134():38-46. PubMed ID: 28342833
[TBL] [Abstract][Full Text] [Related]
2. Transient CHO expression platform for robust antibody production and its enhanced N-glycan sialylation on therapeutic glycoproteins.
Zhong X; Ma W; Meade CL; Tam AS; Llewellyn E; Cornell R; Cote K; Scarcelli JJ; Marshall JK; Tzvetkova B; Figueroa B; DiNino D; Sievers A; Lee C; Guo J; Mahan E; Francis C; Lam K; D'Antona AM; Zollner R; Zhu HL; Kriz R; Somers W; Lin L
Biotechnol Prog; 2019 Jan; 35(1):e2724. PubMed ID: 30299005
[TBL] [Abstract][Full Text] [Related]
3. Large-Scale Transient Production in ExpiCHO-S™ with Enhanced N-Galactosylation-Sialylation and PEI-Based Transfection.
Zhong X; Schwab A; Ma W; Meade CL; Zhou J; D'Antona AM; Somers W; Lin L
Methods Mol Biol; 2022; 2313():143-150. PubMed ID: 34478135
[TBL] [Abstract][Full Text] [Related]
4. Comparison of different transient gene expression systems for the production of a new humanized anti-HER2 monoclonal antibody (Hersintuzumab).
Roshani A; Mohammadi M; Bahadori T; Ahmadi Zare H; Judaki MA; Mobini M; Golsaz-Shirazi F; Jeddi-Tehrani M; Amiri MM; Shokri F
Daru; 2023 Dec; 31(2):221-231. PubMed ID: 37695454
[TBL] [Abstract][Full Text] [Related]
5. A high cell density transient transfection system for therapeutic protein expression based on a CHO GS-knockout cell line: process development and product quality assessment.
Rajendra Y; Hougland MD; Alam R; Morehead TA; Barnard GC
Biotechnol Bioeng; 2015 May; 112(5):977-86. PubMed ID: 25502369
[TBL] [Abstract][Full Text] [Related]
6. High-level protein expression in scalable CHO transient transfection.
Ye J; Kober V; Tellers M; Naji Z; Salmon P; Markusen JF
Biotechnol Bioeng; 2009 Jun; 103(3):542-51. PubMed ID: 19199356
[TBL] [Abstract][Full Text] [Related]
7. Differences in N-glycosylation of recombinant human coagulation factor VII derived from BHK, CHO, and HEK293 cells.
Böhm E; Seyfried BK; Dockal M; Graninger M; Hasslacher M; Neurath M; Konetschny C; Matthiessen P; Mitterer A; Scheiflinger F
BMC Biotechnol; 2015 Sep; 15():87. PubMed ID: 26382581
[TBL] [Abstract][Full Text] [Related]
8. A robust transfection reagent for the transfection of CHO and HEK293 cells and production of recombinant proteins and lentiviral particles - PTG1.
Gonçalves C; Gross F; Guégan P; Cheradame H; Midou P
Biotechnol J; 2014 Nov; 9(11):1380-8. PubMed ID: 25215936
[TBL] [Abstract][Full Text] [Related]
9. Design of Experiment in CHO and HEK transient transfection condition optimization.
Bollin F; Dechavanne V; Chevalet L
Protein Expr Purif; 2011 Jul; 78(1):61-8. PubMed ID: 21354312
[TBL] [Abstract][Full Text] [Related]
10. Small-Scale Cultivation and Transfection of ExpiCHO and HEK293E Cells in Single-Use Orbitally Shaken Bioreactors.
Hacker DL; Durrer L; Quinche S; Lau K; Pojer F
Methods Mol Biol; 2024; 2810():85-98. PubMed ID: 38926274
[TBL] [Abstract][Full Text] [Related]
11. Transient transfection of CHO-K1-S using serum-free medium in suspension: a rapid mammalian protein expression system.
Rosser MP; Xia W; Hartsell S; McCaman M; Zhu Y; Wang S; Harvey S; Bringmann P; Cobb RR
Protein Expr Purif; 2005 Apr; 40(2):237-43. PubMed ID: 15766864
[TBL] [Abstract][Full Text] [Related]
12. Transient transfection factors for high-level recombinant protein production in suspension cultured mammalian cells.
Liu C; Dalby B; Chen W; Kilzer JM; Chiou HC
Mol Biotechnol; 2008 Jun; 39(2):141-53. PubMed ID: 18327552
[TBL] [Abstract][Full Text] [Related]
13. Highly sensitive HPLC analysis and biophysical characterization of N-glycans of IgG-Fc domain in comparison between CHO and 293 cells using FcγRIIIa ligand.
Kosuge H; Nagatoishi S; Kiyoshi M; Ishii-Watabe A; Tanaka T; Terao Y; Oe S; Ide T; Tsumoto K
Biotechnol Prog; 2020 Nov; 36(6):e3016. PubMed ID: 32390308
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional and post-transcriptional limitations of high-yielding, PEI-mediated transient transfection with CHO and HEK-293E cells.
Rajendra Y; Kiseljak D; Baldi L; Wurm FM; Hacker DL
Biotechnol Prog; 2015; 31(2):541-9. PubMed ID: 25683738
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of DNA uptake in FUT8-deleted CHO cells for transient production of afucosylated antibodies.
Wong AW; Baginski TK; Reilly DE
Biotechnol Bioeng; 2010 Aug; 106(5):751-63. PubMed ID: 20564613
[TBL] [Abstract][Full Text] [Related]
16. CHO-S antibody titers >1 gram/liter using flow electroporation-mediated transient gene expression followed by rapid migration to high-yield stable cell lines.
Steger K; Brady J; Wang W; Duskin M; Donato K; Peshwa M
J Biomol Screen; 2015 Apr; 20(4):545-51. PubMed ID: 25520372
[TBL] [Abstract][Full Text] [Related]
17. Auditioning of CHO host cell lines using the artificial chromosome expression (ACE) technology.
Kennard ML; Goosney DL; Monteith D; Roe S; Fischer D; Mott J
Biotechnol Bioeng; 2009 Oct; 104(3):526-39. PubMed ID: 19544304
[TBL] [Abstract][Full Text] [Related]
18. Optimization of a high-cell-density polyethylenimine transfection method for rapid protein production in CHO-EBNA1 cells.
Stuible M; Burlacu A; Perret S; Brochu D; Paul-Roc B; Baardsnes J; Loignon M; Grazzini E; Durocher Y
J Biotechnol; 2018 Sep; 281():39-47. PubMed ID: 29886030
[TBL] [Abstract][Full Text] [Related]
19. Development of a highly-efficient CHO cell line generation system with engineered SV40E promoter.
Fan L; Kadura I; Krebs LE; Larson JL; Bowden DM; Frye CC
J Biotechnol; 2013 Dec; 168(4):652-8. PubMed ID: 23994266
[TBL] [Abstract][Full Text] [Related]
20. Protein production from HEK293 cell line-derived stable pools with high protein quality and quantity to support discovery research.
Sun H; Wang S; Lu M; Tinberg CE; Alba BM
PLoS One; 2023; 18(6):e0285971. PubMed ID: 37267316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
